GSK Plc (GSK)
49.24
-0.41
(-0.83%)
USD |
NYSE |
Sep 25, 16:00
49.31
+0.07
(+0.14%)
Pre-Market: 19:59
GSK Price : 49.24 for Sept. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | 49.49 | 49.50 | 49.00 | 49.24 | 3.324M |
| Sep 24, 2026 | 49.59 | 50.14 | 49.56 | 49.65 | 2.839M |
| Sep 23, 2026 | 50.18 | 50.74 | 49.67 | 49.71 | 3.041M |
| Sep 22, 2026 | 50.69 | 50.99 | 50.22 | 50.72 | 4.296M |
| Sep 21, 2026 | 50.75 | 51.32 | 50.46 | 51.08 | 2.872M |
| Sep 18, 2026 | 50.20 | 50.33 | 49.50 | 50.22 | 4.709M |
| Sep 17, 2026 | 50.72 | 51.08 | 50.62 | 51.06 | 3.075M |
| Sep 16, 2026 | 50.19 | 50.71 | 50.06 | 50.29 | 2.845M |
| Sep 15, 2026 | 49.69 | 50.16 | 49.63 | 50.01 | 2.740M |
| Sep 14, 2026 | 50.29 | 50.30 | 49.61 | 50.05 | 3.004M |
| Sep 11, 2026 | 48.70 | 48.80 | 47.85 | 48.13 | 2.277M |
| Sep 10, 2026 | 48.47 | 48.59 | 47.98 | 48.12 | 2.151M |
| Sep 09, 2026 | 48.82 | 49.16 | 48.60 | 48.63 | 2.405M |
| Sep 08, 2026 | 49.00 | 49.23 | 48.54 | 48.54 | 3.062M |
| Sep 04, 2026 | 49.70 | 50.06 | 49.66 | 49.89 | 2.287M |
| Sep 03, 2026 | 51.50 | 51.52 | 50.19 | 50.87 | 2.443M |
| Sep 02, 2026 | 50.36 | 51.08 | 50.04 | 50.44 | 2.938M |
| Sep 01, 2026 | 51.11 | 51.26 | 50.46 | 50.66 | 3.272M |
| Aug 31, 2026 | 50.62 | 50.82 | 50.25 | 50.25 | 2.394M |
| Aug 28, 2026 | 50.22 | 50.88 | 49.95 | 50.82 | 3.432M |
| Aug 27, 2026 | 50.94 | 51.03 | 50.16 | 50.27 | 2.466M |
| Aug 26, 2026 | 51.90 | 52.09 | 51.40 | 51.43 | 1.717M |
| Aug 25, 2026 | 51.57 | 52.21 | 51.51 | 52.07 | 2.699M |
| Aug 24, 2026 | 51.54 | 51.95 | 51.40 | 51.78 | 2.886M |
| Aug 21, 2026 | 51.35 | 52.57 | 51.35 | 52.41 | 2.405M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 166.58 |
| Johnson & Johnson | 271.22 |
| Eli Lilly & Co. | 1183.46 |
| Merck & Co., Inc. | 148.78 |
| Novo Nordisk A/S | 38.80 |
Price Related Metrics
| PE Ratio | 15.51 |
| PS Ratio | 2.255 |
| PEG Ratio | 0.3235 |
| Price to Book Value | 4.253 |
| Price to Free Cash Flow | 15.18 |
| Earnings Yield | 6.45% |
| Market Cap | 99.60B |
| PEGY Ratio | 0.3002 |
| Operating PE Ratio | 9.020 |
| Normalized PE Ratio | 10.68 |